Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 6
1970 2
1973 2
1974 3
1975 2
1976 4
1977 3
1978 3
1979 2
1980 4
1981 3
1982 5
1983 4
1984 7
1985 5
1986 12
1987 7
1988 7
1989 13
1990 12
1991 7
1992 16
1993 12
1994 9
1995 15
1996 12
1997 10
1998 20
1999 11
2000 17
2001 12
2002 10
2003 18
2004 15
2005 15
2006 7
2007 10
2008 13
2009 16
2010 20
2011 17
2012 12
2013 6
2014 4
2015 8
2016 8
2017 7
2018 8
2019 10
2020 11
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

444 results
Results by year
Filters applied: . Clear all
Page 1
Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.
Wu YL, Cheng Y, Zhou X, Lee KH, Nakagawa K, Niho S, Tsuji F, Linke R, Rosell R, Corral J, Migliorino MR, Pluzanski A, Sbar EI, Wang T, White JL, Nadanaciva S, Sandin R, Mok TS. Wu YL, et al. Among authors: linke r. Lancet Oncol. 2017 Nov;18(11):1454-1466. doi: 10.1016/S1470-2045(17)30608-3. Epub 2017 Sep 25. Lancet Oncol. 2017. PMID: 28958502 Clinical Trial.
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
Mok TS, Cheng Y, Zhou X, Lee KH, Nakagawa K, Niho S, Lee M, Linke R, Rosell R, Corral J, Migliorino MR, Pluzanski A, Sbar EI, Wang T, White JL, Wu YL. Mok TS, et al. Among authors: linke r. J Clin Oncol. 2018 Aug 1;36(22):2244-2250. doi: 10.1200/JCO.2018.78.7994. Epub 2018 Jun 4. J Clin Oncol. 2018. PMID: 29864379 Clinical Trial.
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial.
Gross-Goupil M, Kwon TG, Eto M, Ye D, Miyake H, Seo SI, Byun SS, Lee JL, Master V, Jin J, DeBenedetto R, Linke R, Casey M, Rosbrook B, Lechuga M, Valota O, Grande E, Quinn DI. Gross-Goupil M, et al. Among authors: linke r. Ann Oncol. 2018 Dec 1;29(12):2371-2378. doi: 10.1093/annonc/mdy454. Ann Oncol. 2018. PMID: 30346481 Free PMC article. Clinical Trial.
Evaluation of diagnostic tests for infectious diseases: general principles.
Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, Smith PG, Sriram N, Wongsrichanalai C, Linke R, O'Brien R, Perkins M, Cunningham J, Matsoso P, Nathanson CM, Olliaro P, Peeling RW, Ramsay A; TDR Diagnostics Evaluation Expert Panel (WHO/TDR) 2006. Banoo S, et al. Among authors: linke r. Nat Rev Microbiol. 2006 Sep;4(9 Suppl):S21-31. doi: 10.1038/nrmicro1523. Nat Rev Microbiol. 2006. PMID: 17034069 No abstract available.
Immune Sensing of Synthetic, Bacterial, and Protozoan RNA by Toll-like Receptor 8 Requires Coordinated Processing by RNase T2 and RNase 2.
Ostendorf T, Zillinger T, Andryka K, Schlee-Guimaraes TM, Schmitz S, Marx S, Bayrak K, Linke R, Salgert S, Wegner J, Grasser T, Bauersachs S, Soltesz L, Hübner MP, Nastaly M, Coch C, Kettwig M, Roehl I, Henneke M, Hoerauf A, Barchet W, Gärtner J, Schlee M, Hartmann G, Bartok E. Ostendorf T, et al. Among authors: linke r. Immunity. 2020 Apr 14;52(4):591-605.e6. doi: 10.1016/j.immuni.2020.03.009. Immunity. 2020. PMID: 32294405
AMYLOIDOSIS IN CARACALS (CARACAL CARACAL).
Greunz EM, Lemberger K, Catinaud J, Chenet B, Linke RP, Bräsen JH, Schmitz J, Bertelsen MF. Greunz EM, et al. Among authors: linke rp. J Zoo Wildl Med. 2020 Mar 17;51(1):202-209. doi: 10.1638/2019-0005. J Zoo Wildl Med. 2020. PMID: 32212564
Structured reporting of head and neck ultrasound examinations.
Ernst BP, Hodeib M, Strieth S, Künzel J, Bischof F, Hackenberg B, Huppertz T, Weber V, Bahr K, Eckrich J, Hagemann J, Engelbarts M, Froelich MF, Solbach P, Linke R, Matthias C, Sommer WH, Becker S. Ernst BP, et al. Among authors: linke r. BMC Med Imaging. 2019 Mar 27;19(1):25. doi: 10.1186/s12880-019-0325-5. BMC Med Imaging. 2019. PMID: 30917796 Free PMC article.
FDG-pet in paraneoplastic syndromes.
Linke R, Voltz R. Linke R, et al. Recent Results Cancer Res. 2008;170:203-11. doi: 10.1007/978-3-540-31203-1_16. Recent Results Cancer Res. 2008. PMID: 18019628 Review.
444 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page